DelveInsight launched a new report on Vaso-Occlusive Crisis Epidemiology Forecast, 2030.
The Vaso-Occlusive Crisis, or sickle cell crisis, is defined as pain resulting from tissue ischemia caused by vaso-occlusion, most commonly in the bone(s) and bone marrow. It is the most frequent, painful, and debilitating symptom of Sickle-cell disease (SCD) which typically occurs in the extremities, back, joints, abdomen, or chest. It is initiated and sustained by interactions among sickle cells, endothelial cells, and plasma constituents.
DelveInsight’s ‘Vaso-Occlusive Crisis Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Vaso-Occlusive Crisis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Vaso-Occlusive Crisis Epidemiology Report:
Epidemiologic data indicate that 5.2% of patients with SCD have 3–10 episodes of severe pain every year. These severe and unpredictable painful attacks were responsible for >90% of acute hospital admissions and Vaso-occlusive crisis, which constitutes the major morbidity in SCD.
Patients with homozygous sickle cell and sickle cell–β°-thalassemia have a higher frequency of Vaso-Occlusive Crisis than patients with hemoglobin SC and sickle cell–β+-thalassemia genotypes.
Visit for more @ Vaso-Occlusive Crisis Epidemiology Insights
Scope of the Vaso-Occlusive Crisis Epidemiology report:
The Vaso-Occlusive Crisis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Vaso-Occlusive Crisis Epidemiology Report and Model provide an overview of the risk factors and global trends of the Vaso-Occlusive Crisis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of the Vaso-Occlusive Crisis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of the Vaso-Occlusive Crisis
The report provides the segmentation of the Vaso-Occlusive Crisis epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Vaso-Occlusive Crisis
3. Vaso-Occlusive Crisis Epidemiology Overview at a Glance
4. Vaso-Occlusive Crisis: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Vaso-Occlusive Crisis
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Vaso-Occlusive Crisis-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Vaso-Occlusive Crisis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Vaso-Occlusive Crisis market. A detailed picture of the Vaso-Occlusive Crisis pipeline landscape is provided, which includes the disease overview and Vaso-Occlusive Crisis treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States